Assessment of pre-extubating recurrent laryngeal nerve palsy using ultrasound in postoperative patients with esophageal cancer: a prospective observational study
Journal of Anesthesia · 2024
DOI: 10.1007/s00540-024-03315-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Anesthesia, 2024. Verfasst von Tomomi Kaneko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe-city, Saitama, 350-8550, Japan. tomomi_k@saita…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Vocal Cord Paralysis, Ultrasonography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saitama Medical University.
Abstract (Originalsprache)
Purpose
Ultrasound performed after extubation has been suggested to be useful for the diagnosis of recurrent laryngeal nerve (RLN) paralysis. However, the use of ultrasound for this purpose before extubation has not been examined. The aim of this study was to examine the versatility (interrater reliability) and usefulness of ultrasound for evaluating the movement of vocal cords before extubation.
Methods
The subjects were 30 patients who underwent radical surgery for esophageal cancer from August 2020 to December 2021. An experienced examiner performed an ultrasound examination before and after elective extubation on the day after surgery to evaluate RLN paralysis and record videos. Bronchoscopy was then performed to make a definite diagnosis. Three anesthetists blinded to the diagnosis also evaluated the cases using the videos, and the versatility of the examination was determined using a kappa test.
Results
The diagnostic accuracies of the examiner and three anesthetists were 76.7%, 50.0%, 53.3%, and 46.7%, respectively, and the kappa coefficients for the examiner with the anesthetists were 0.310, 0.502, and 0.169, respectively. The sensitivity, specificity, positive predictive value and negative predictive value for diagnosis of RLN paralysis by the examiner using ultrasound before extubation were 0.57, 0.95, 0.80, and 0.87, respectively.
Conclusion
These results indicate a lack of versatility of the ultrasound examination based on the low kappa coefficients. However, with an experienced examiner, ultrasound can serve as a non-invasive examination that can be performed before extubation with high accuracy and specificity for diagnosis of postoperative RLN paralysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe-city, Saitama, 350-8550, Japan. tomomi_k@saitama-med.ac.jp.
- Department of Anesthesiology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe-city, Saitama, 350-8550, Japan.
- Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba, Japan.
- Faculty of Nursing, Japanese Red Cross College of Nursing, Tokyo, Japan.
Förderung
- Saitama Medical University
Zitieren
APA
Kaneko, T., Kato, T., Shiko, Y., Kawasaki, Y., & Koyama, K. (2024). Assessment of pre-extubating recurrent laryngeal nerve palsy using ultrasound in postoperative patients with esophageal cancer: a prospective observational study. Journal of Anesthesia. https://doi.org/10.1007/s00540-024-03315-7
Vancouver
Kaneko T, Kato T, Shiko Y, Kawasaki Y, Koyama K. Assessment of pre-extubating recurrent laryngeal nerve palsy using ultrasound in postoperative patients with esophageal cancer: a prospective observational study. Journal of Anesthesia. 2024. doi:10.1007/s00540-024-03315-7
BibTeX
@article{Kaneko2024,
author = {Kaneko, Tomomi and Kato, Takao and Shiko, Yuki and Kawasaki, Yohei and Koyama, Kaoru},
title = {Assessment of pre-extubating recurrent laryngeal nerve palsy using ultrasound in postoperative patients with esophageal cancer: a prospective observational study},
journal = {Journal of Anesthesia},
year = {2024},
doi = {10.1007/s00540-024-03315-7}
}
EUVIMED